5443092026-04-012026-06-305443092026-04-012026-06-30in-capmkt:OtherExpenses1Member5443092026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15443092026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25443092026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss15443092026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares544309IKSNOTLISTEDINE115Q01022INVENTURUS KNOWLEDGE SOLUTIONS LIMITEDMain BoardEquity2026-04-012027-03-312026-08-052026-07-28INRMillionsQuarterlyFirst quarterSingle segmentCare enablement platform providing technology enabled solutions to healthcare providers2026-08-0519:15:002026-08-0520:44:00Not applicable2026-04-012026-06-30UnauditedConsolidated8936290000571000008993390000-162000045501000000010110000034289000014384100006430880000256251000002562510000682980000-11095000057203000001990480000000-53070000193741000046232000023997300000000170850000111.5511.310011.5511.31Notes to the Statement of Unaudited Consolidated and Standalone Financial Results for the quarter ended June 30, 2026: <br /> <br /> 1. The above standalone financial results of Inventurus Knowledge Solutions Limited ("the Company") and consolidated financial results of the Company and its subsidiaries (collectively "the Group") and its interest in associate for the quarter ended June 30, 2026 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in it's meeting held on August 5, 2026. The above results for the quarter ended June 30, 2026 have been reviewed by the Statutory Auditors of the Company in terms of Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. <br /> <br /> 2. The statement has been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards("Ind AS") as prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder. <br /> <br /> 3. The figures of the quarter ended March 31, 2026 are balancing figures between audited figures in respect of the full financial year and the published year to date figures up to the third quarter of the financial year ended March 31, 2026. <br /> <br /> 4. The Group operates in one reportable business segment which comprises a Care enablement platform providing technology enabled solutions to Healthcare providers. This in the context of Indian Accounting Standard (Ind AS 108) "Operating Segments", constitutes a single operating segment. <br /> <br /> 5. The Company has allotted 140,085 shares for the quarter ended June 30, 2026 (quarter ended June 30, 2025 : 23,942 shares) to eligible employees on exercise of Employee Stock options, in accordance with the terms and conditions of the IKS Employees Stock Options Plan 2022 named 'IKS Health - ESOP Policy 2022' as approved by the shareholders of the Company on April 22, 2022. Further, during the quarter ended June 30, 2026, the Company has granted 143,814 stock options to eligible employees, as approved by the Nomination and Remuneration Committee. <br /> <br /> 6. Earnings per share for the interim periods are not annualised. <br /> <br /> 7. The consolidated financial results of the Group include the results of its subsidiary companies viz: Inventurus Knowledge Solutions Inc ("IKS Inc."), IKS Cares Foundation, Arai Solutions Private Limited and its step down subsidiary companies viz: Aquity Holdings Inc, Aquity Solutions LLC, Aquity Solutions India Private Limited, Aquity Solutions Australia Pty Limited, Aquity Canada ULC, IKS Next Horizon, Inc and Value Partners Collective ACO, LLC. <br /> <br /> 8. During the quarter ended June 30, 2026, IKS Inc., a US-incorporated step-down subsidiary of the Company, acquired an additional 3.86% equity interest in IKS WWMG MSO LLC ("the Investee"), increasing the Group's aggregate shareholding from 48.02% to 51.88%, effective June 30, 2026, being the last day of the reporting period. As control was obtained on the last day of the quarter, there was no post-acquisition operating period during the current quarter. Accordingly, the Investee's results for the quarter continue to be accounted for under the equity method, and the acquisition has had no material impact on the Group's consolidated Statement of Profit and Loss for the quarter ended June 30, 2026. <br /> <br /> As control of the Investee was obtained on June 30, 2026, being the last day of the reporting period, the initial accounting for the business combination — including the determination of the acquisition-date fair value of the Group's previously held 48.02% equity interest is incomplete as at the reporting date, pending finalisation of the purchase price allocation. In accordance with Ind AS 103, the Group has accounted for the acquisition on a provisional basis as at June 30, 2026, and no remeasurement gain/loss on the previously held equity interest has been recognised in the current quarter's Statement of Profit and Loss. The Group will complete the purchase price allocation, including remeasurement of the previously held interest to acquisition date fair value, within the measurement period (not exceeding twelve months from the acquisition date, as permitted under Ind AS 103), and any resulting adjustments including the remeasurement gain/loss will be recognised retrospectively from the acquisition date once finalised. <br /> <br /> 9. On April 23, 2026, IKS Inc., a wholly owned US subsidiary of the Company, entered into a definitive agreement to acquire TruBridge, Inc. for an enterprise value of up to US$557 million, as disclosed in the audited consolidated financial statements for the year ended March 31, 2026. The acquisition was completed on July 9, 2026, after the quarter end but before approval of these results, making it a non-adjusting subsequent event under Ind AS 10 ‘Events after the Reporting Period’. Accordingly, no adjustments have been made to the results for the quarter ended June 30, 2026. <br /> <br /> Prior to completing its acquisition of TruBridge, Inc., the Company entered into a material pre-existing relationship with TruBridge, Inc. for the sale of certain software licenses. Revenue related to this agreement was recognised during the quarter. In accordance with Ind AS 103, ‘Business Combinations’, management evaluated the transaction and concluded that it is separate from, and not part of, the business combination transaction. Consequently, the transaction has been accounted for in accordance with Ind AS 115 ‘Revenue from Contracts with Customers’ <br /> <br /> 10. On May 14, 2026 (“acquisition date”), Inventurus Knowledge Solutions Limited (“the Company”/“the Holding Company”) acquired 10,000 equity shares of face value INR 10 each, representing 100% of the paid-up equity share capital of Arai Solutions Private Limited (“Arai” or “the acquiree”), for a total cash consideration of INR 11,00,00,000, thereby obtaining control over Arai in accordance with Ind AS 110. Consequently, Arai has become a subsidiary of the Company with effect from the acquisition date. The consideration transferred for the acquisition of Arai comprised cash consideration of INR 11,00,00,000, paid in full on the acquisition date. No contingent consideration or equity instruments were issued as part of the arrangement. <br /> <br /> In accordance with Ind AS 103, Business Combinations, the acquisition has been accounted for using the acquisition method. As at the date of approval of these financial statements, the Group has not completed the exercise of identifying and measuring the fair values of the identifiable assets acquired and liabilities assumed (including intangible assets and contingent liabilities, if any) and the resultant goodwill/capital reserve arising on the acquisition. Accordingly, the purchase price allocation (“PPA”) has been accounted for on a provisional basis in these financial statements. <br /> <br /> The Group will complete the PPA exercise within the measurement period, not exceeding twelve months from the acquisition date, as permitted under Ind AS 103. Any adjustments to the provisional amounts identified within the measurement period, arising from new information obtained about facts and circumstances existing as at the acquisition date, will be recognised retrospectively, with corresponding adjustments to goodwill. Adjustments to provisional amounts after the measurement period will be recognised in the Statement of Profit and Loss.Other Expenses1438410000Remeasurement of post employment benefit obligations8910000Changes in the fair value of equity investments at FVOCI22642000023533000056860000Gains/ (losses) on cash flow hedges (net)359930000Exchange differences on translation of financial statements of foreign operations-50000035943000075580000462320000